Brain changes and weight loss medication for teens and adults with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a medication that helps with weight loss, called a GLP-1 agonist, can also change how the brain works. It is for teenagers (12-18) and adults (30-45) with obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You speak English
- You are between 12 and 18 years old with a very high BMI, or between 30 and 45 years old with a BMI over 35
- You have not used a GLP-1 medication (like Ozempic or Wegovy) in the last 3 months
- You are not taking antipsychotic medications (antidepressants are okay)
- You do not have type 2 diabetes
- You are not currently pregnant, breastfeeding, or planning pregnancy (for females)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
This trial tests a GLP-1 medication (a drug that helps control appetite and blood sugar) combined with a lifestyle program for teens with severe obesity. The goal is to see if this approach can improve overall health and well-being.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Hear when a new Obesity/Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.